Covalab and partners CimCure, Amsterdam UMC and the University of Zurich join forces on this project with total public and private fundings of €2.24M, including the Eurostars grant, to develop novel immunotherapy combining CAR-T cells and CimCure’s iBoost vaccines to treat glioblastoma
Read morePolyplus, a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial grade, continues to build out the mRNA support portfolio
Read moreThe European Medicines Agency (EMA) has granted Orphan Drug Designation to ONCO-Boost (HEPHAISTOS-Pharma) as treatment for osteosarcoma.
Read moreCREAPHARM DEMONSTRATES UNPARALLELED PERFORMANCE OF -80°C NITROGEN TANK TECHNOLOGY.
Read moreABL, a Contract Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of virus for vaccine candidates, gene and cancer therapies, today announces its partnership with KaliVir Immunotherapeutics.
Read moreThis is a unique website which will require a more modern browser to work!
Please upgrade today!
